MetLife Investment Advisors »

Viking Therapeutics shares owned by MetLife Investment Advisors

Quarter-by-quarter ownership of Viking Therapeutics (VKTX) shares owned by MetLife Investment Advisors from 13F filings

Historical chart of MetLife Investment Advisors investment in Viking Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Viking Therapeutics held by MetLife Investment Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Viking Therapeutics by MetLife Investment Advisors

Quarter filed Position value Share count Share price at filing
2023-12-31 $944k 51k 18.61
2023-09-30 $561k 51k 11.07
2023-06-30 $822k 51k 16.21
2022-03-31 $21k 7.0k 2.98
2021-12-31 $122k 27k 4.60
2021-09-30 $94k 15k 6.28
2021-06-30 $165k 28k 5.99
2021-03-31 $58k 9.1k 6.33
2020-12-31 $168k 30k 5.63
2020-09-30 $166k 29k 5.80
2020-06-30 $206k 29k 7.20
2020-03-31 $134k 29k 4.69
2019-12-31 $229k 29k 8.01
2019-09-30 $197k 29k 6.89
2019-06-30 $237k 29k 8.30
2019-03-31 $284k 29k 9.93
2018-12-31 $219k 29k 7.65
2018-09-30 $378k 22k 17.42
2018-06-30 $206k 22k 9.49